<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03832439</url>
  </required_header>
  <id_info>
    <org_study_id>16-003300</org_study_id>
    <nct_id>NCT03832439</nct_id>
  </id_info>
  <brief_title>Probiotic Supplementation on Weight Loss</brief_title>
  <official_title>The Effect of Probiotic Supplementation on Weight Loss, and Its Association With the Gut Microbiome After Bariatric Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are trying to better understand how bariatric surgery leads to weight loss,
      and the role of bacteria that live in the gut in making this happen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are interested in seeing how a probiotic, which is a dietary supplement
      containing large amounts of 'good' bacteria, can influence the make-up of the gut bacterial
      population and what effect it has on weight loss and loss of fat. Before undergoing weight
      loss surgery (sleeve gastrectomy or roux-en-y gastric bypass), study participants will be
      asked to provide a stool sample to assess the make-up of their gut bacterial population. They
      will also undergo a limited CT scan of the abdomen and DEXA (Xray) to help assess the amount
      of fat present inside the body.

      After undergoing weight loss surgery (sleeve gastrectomy or roux-en-y gastric bypass), study
      participants will be given either a probiotic supplement or dummy pill (placebo) for 3
      months, in addition to all usual care that occurs after surgery. The CT scan, DEXA scan and
      stool sample will be repeated at the end of the 3 month period and analyzed for changes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>3 months</time_frame>
    <description>Change in body weight from baseline to 3 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visceral fat loss</measure>
    <time_frame>3 months</time_frame>
    <description>Change in visceral fat from baseline to 3 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will be receiving probiotic supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This arm will be receiving placebo containing microcrystalline cellulose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>Lactobacillus rhamnosus GG 10 billion cells and microcrystalline cellulose</description>
    <arm_group_label>Probiotic</arm_group_label>
    <other_name>CulturelleÂ®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>microcrystalline cellulose</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All subjects who are &gt; 18 and &lt; 65 years of age recruited from the Mayo Clinic
             bariatric surgery clinic

          2. Will also meet one of the National Institute of Health's criteria for bariatric
             surgery, i.e. body mass index (BMI) &gt; 40 kg/m2 or BMI &gt; 35 kg/m2 with significant
             weight-related comorbidities.

          3. Patients will be eligible if they are not on chronic antibiotic therapy and without
             active systemic illness.

        Exclusion Criteria:

          1. Patients with type 1 or 2 diabetes will be excluded due to the known pre-existing
             changes in the gut microbiome in this population. All patients will not have had
             exposure to probiotics, prebiotics or antibiotics in the preceding 4 weeks.

          2. Patients with allergy to antibiotics precluding the use of standard peri-operative
             antibiotics (cefazolin and metronidazole) will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meera Shah, M.B., Ch.B</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vishakantha Murthy, PhD</last_name>
    <phone>507-255-8112</phone>
    <email>Murthy.Vishakantha@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vishakantha Murthy, PhD</last_name>
      <phone>507-255-8112</phone>
      <email>Murthy.Vishakantha@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Meera Shah, M.B., Ch.B</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2019</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Meera Shah, M.B., Ch.B.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Probiotic</keyword>
  <keyword>Microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

